Pricing Log in Create free account

Trinity Biotech PLC (TRIB) vs Vivos Therapeutics, Inc. (VVOS)

Trinity Biotech PLC and Vivos Therapeutics, Inc. are both Medical Devices companies. Trinity Biotech PLC and Vivos Therapeutics, Inc. are of similar size ($3.8M and $3.5M). Vivos Therapeutics, Inc. grew revenue faster over the last twelve months: 45.2% against −13.5%. Trinity Biotech PLC has the higher net margin (−70.1% vs −121.8%) and the higher return on invested capital (−12.6% vs −592.7%). Across the 17 metrics below, Trinity Biotech PLC leads on 9 and Vivos Therapeutics, Inc. on 8.

Valuation

Metric TRIB VVOS Medical Devices median
P/E n/m n/m 24.94
P/S 0.08 0.08 2.66
P/B n/m n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 2.95 0.38 2.76
Earnings yield (855.10%) (2,111.11%) (12.66%)
Free cash flow yield (322.13%) (1,194.75%) (7.18%)

Profitability

Metric TRIB VVOS Medical Devices median
Gross margin 39.99% 61.89% 57.76%
Operating margin (25.43%) (107.89%) (14.84%)
Net margin (70.07%) (121.79%) (14.45%)
Free cash flow margin (9.10%) (90.97%) (5.70%)
Return on equity 55.26% 10,022.05% (10.56%)
Return on assets (32.70%) (101.46%) (17.26%)
Return on invested capital (12.61%) (592.70%) (5.22%)

Growth

Metric TRIB VVOS Medical Devices median
Revenue growth (TTM) (13.52%) 45.21% 10.41%
EPS growth (last fiscal year) (12.99%) 6.76% 28.17%
Revenue growth, 5-year CAGR (15.56%) 5.95% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TRIB VVOS Medical Devices median
Debt to equity (1.81) (2.04) 0.04
Current ratio 0.22 0.21 2.67
Net debt to EBITDA (9.92) (0.37) 0.54

Dividend

Metric TRIB VVOS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric TRIB VVOS Medical Devices median
Market cap 3.77m 3.45m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack